Infectious Disease Clinics of North America volume 20, issue 1, P155-174 2006 DOI: 10.1016/j.idc.2006.01.011 View full text
|
|
Share
Scott W. Biggins, Norah A. Terrault

Abstract: Recurrent HCV infection is universal in liver transplant recipients who are viremic pretransplant. The rate of histologic disease progression after transplantation is more rapid, and the risk of cirrhosis by 5 to 10 years is about 30%. Several donor, recipient, and viral factors have been associated with worse post-transplant outcomes in recipients with recurrent hepatitis C. Whether or not HCV-infected recipients of live donor grafts have worse out-comes compared with deceased donor graft recipients is contro…

expand abstract